PRRT2 and choreatic disease: PKD patients with PRRT2 mutations (PKD‐M) show distinct clinical manifestations including earlier age of onset and longer duration of attacks, complex phenotypes of dystonia and chorea, and more tendency for a family history compared to PKD patients without PRRT2 mutations (PKD‐N) (Huang et al., 2015).